Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species

Katiria Soto-Diaz1, Mario Vailati-Riboni2, Allison Y Louie1

  • 1Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL, United States.

Frontiers in Immunology
|December 13, 2021
PubMed

Insights

GW2580, a colony stimulating factor receptor 1 (CSF1R) antagonist, alters microglia morphology and survival pathways without affecting body weight or behavior. This suggests partial CSF1R antagonism sensitizes microglia to oxidative stress.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia, the brain's immune cells, are implicated in neurodegenerative diseases.
  • Interleukin-34 (IL-34) and colony stimulating factor-1 (CSF-1) regulate microglia survival and function via CSF1R.
  • The effects of non-CNS-penetrant CSF1R antagonists on normal microglia physiology are not well understood.

Purpose of the Study:

  • To investigate the impact of the non-penetrant CSF1R antagonist GW2580 on microglia function and physiology in healthy mice.
  • To determine if GW2580 affects microglia viability, morphology, or gene expression.
  • To assess the susceptibility of GW2580-treated microglia to oxidative stress.

Main Methods:

  • C57BL/6J mice were treated with GW2580 (80mg/kg/d) or vehicle for 8 days.
  • Assessed body weight, burrowing behavior, circulating leukocytes, and microglia morphology (Iba-1 staining).
  • Analyzed microglia transcriptome via RNA-sequencing and tested viability in primary cultures with LPS and ROS inhibitors.

Main Results:

  • GW2580 treatment did not alter body weight, burrowing behavior, or circulating leukocytes.
  • Microglia morphology was altered, but cell numbers remained unchanged.
  • RNA-sequencing revealed suppressed genes related to reactive oxygen species (ROS) regulation and survival.
  • GW2580 reduced microglia viability when combined with LPS (ROS inducer) and sensitized them to hydrogen peroxide-induced death.

Conclusions:

  • Partial CSF1R antagonism with GW2580 alters microglia morphology and gene expression related to ROS and survival.
  • GW2580 treatment alone does not reduce microglia viability but sensitizes them to oxidative and nitrosative stress.
  • These findings suggest that targeting CSF1R with non-penetrant antagonists may influence microglia's response to inflammatory and oxidative conditions.

Related Concept Videos